Sign in
Knowstox

Fundamentals snapshot

Kewaunee Scientific Corporation

KEQU · NGM · Consumer Cyclical · Furnishings, Fixtures & Appliances

Current price

$32.19

52-week range

$32.00 - $46.57

Market cap

$93.20M

One-glance verdict

Undervalued

$94.86 our estimate vs market $32.19

Balance sheet

Watch

4.33x Stretched

Net debt $47.23M. Interest coverage shows how many times profit covers the interest bill.

What this company does

Kewaunee Scientific Corporation

Kewaunee Scientific Corporation makes and installs furniture and equipment for science labs and healthcare facilities, which is where most of their money comes from. Their products, like cabinets and specialized work surfaces, are essential for companies doing research and development, meaning their sales can be a good indicator of how much these important industries are investing in new projects. This reliance on industry spending means their overall profit margins (the percentage of money left after paying for the costs of making and selling their products) can fluctuate based on how busy those industries are.

Price history

How the share price has moved

—
Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2025 Q2 $7.75M FY2025 Q3 $-2.96M FY2025 Q4 $8.89M FY2026 Q1 $5.02M FY2026 Q2 $-5.83M FY2026 Q3 $10.98M FY2026 Q4 $4.53M FY2027 Q1 $1.20M
Revenue $66.32M
Net income $1.71M
Diluted EPS 0.58
Operating cash flow $1.98M
Free cash flow $1.20M
Revenue $71.40M
Net income $3.39M
Diluted EPS 1.13
Operating cash flow $5.46M
Free cash flow $4.53M
Revenue $69.40M
Net income $692.00K
Diluted EPS 0.23
Operating cash flow $11.65M
Free cash flow $10.98M
Revenue $70.10M
Net income $2.44M
Diluted EPS 0.82
Operating cash flow $-4.26M
Free cash flow $-5.83M
Revenue $71.10M
Net income $3.09M
Diluted EPS 1.04
Operating cash flow $5.79M
Free cash flow $5.02M
Revenue $77.15M
Net income $4.85M
Diluted EPS 1.63
Operating cash flow $9.41M
Free cash flow $8.89M
Revenue $67.17M
Net income $1.35M
Diluted EPS 0.45
Operating cash flow $-2.27M
Free cash flow $-2.96M
Revenue $47.76M
Net income $3.01M
Diluted EPS 1.01
Operating cash flow $8.44M
Free cash flow $7.75M

Is it cheap or expensive?

Fair value $94.86 vs current price $32.19

Our most-likely fair value is $94.86 a share — about 194.7% above today's price of $32.19, so the stock currently looks cheap (undervalued).

undervalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 2.5% · Discount 7.2% · Terminal 2.5%

$94.86

Bear

Growth 2.5% · Discount 7.2% · Terminal 2.5%

$94.86

Bull

Growth 5.5% · Discount 7.2% · Terminal 2.5%

$116.49

Is it drowning in debt?

Watch

Net debt $47.2M. Interest coverage 4.3x.

Net debt $47.23M
Interest coverage 4.33x

Kewaunee Scientific Corporation's profit covers its interest bill about 4.3 times over. which is stronger than most peers shown here.

Watch
Worse cushion Baseline Better cushion
KEQU BASELINE Kewaunee Scientific Corporation

Total debt $55.47M Interest coverage 4.33x This is the baseline the peer rows are being compared against.

4.33x
HNI HNI Corporation

Total debt $1.64B Interest coverage 6.72x +55% vs KEQU Carries about 1.6x more debt cushion than KEQU.

6.72x +55% vs KEQU
ATHM Autohome Inc.

Total debt $6.84M Interest coverage 1.17x -73% vs KEQU Carries about 3.7x less debt cushion than KEQU.

1.17x -73% vs KEQU
WCC WESCO International, Inc.

Total debt $6.71B Interest coverage 3.19x -26% vs KEQU Carries about 1.4x less debt cushion than KEQU.

3.19x -26% vs KEQU

What you should know

The case for and against KEQU

3 Rewards 2 Risks

Rewards

  • Returns 12.5% on equity, ahead of 50% of its peers.
  • Free cash flow was positive in 5/10 years.
  • Trades at 11.6x P/E vs peer median 20.8x (44.4% cheaper).

Risks

  • Forward P/E (14.9x) is higher than trailing (11.6x) - earnings are expected to drop.
  • Net debt grew 317.6% over 3 years.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
11.58x
Forward P/E
14.90x
P/B
1.24x
P/S
0.34x
EV/EBITDA
6.67x
PEG ratio
—

Profitability

How much profit each dollar creates

Gross margin
28.6%
Operating margin
4.8%
Net margin
3.0%
ROE
12.5%
ROA
5.1%

Health

Liquidity and balance-sheet strength

Debt / equity
0.72x
Current ratio
2.20x
Quick ratio
1.41x
Total debt
$55.47M
Total cash
$8.25M

Growth

How the business has been compounding

Revenue TTM
$277.21M
Revenue 5Y CAGR
13.7%
EPS TTM
2.78
EPS 5Y CAGR
134.4%

Cash flow

How much cash the business throws off

Operating CF TTM
$14.82M
Free CF TTM
$14.70M
FCF margin
5.3%

Dividend

Shareholder payout

Yield
0.0%
Payout ratio
0.0%
Last ex-div date
2019-09-09